Revenue Growth
Revenue was $32.5 million, up 2% sequentially and 29% year-over-year, driven by strong new customer growth and expanding deployments.
Annual Recurring Revenue (ARR)
ARR at June 30, 2025, was $110.5 million, reflecting growth of 27% year-over-year.
Positive Adjusted EBITDA
Reported third consecutive quarter of positive adjusted EBITDA with a margin of 6% in Q2 '25.
Increased Liquidity
Total cash, cash equivalents, and marketable securities increased $2 million sequentially in Q2 '25 to $37 million.
Customer Growth
Welcomed over 60 new customers in the second quarter, now serving over 1,000 customers globally.
Settlement of Legal Issues
The DOJ informed Evolv that the company is no longer the subject of an investigation, and a settlement in principle was reached regarding a securities class action lawsuit.
Significant Wins in Key Markets
Secured a $15 million contract with Gwinnett County Public Schools and several new healthcare and sports facilities.
Raised Full-Year Guidance
Raised revenue growth expectations to 27% to 30% for 2025 from prior guidance of 20% to 25% growth.